Name: Vor Biopharma Inc. (VOR) Financial Statements
Creator: FinSpry

Vor Biopharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Vor Biopharma Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	93.31	94.32	64.55	47.53	31.62
Selling, General & Administrative	27.88	31.72	28.87	21.49	11.75
Operating Expenses	121.19	126.04	93.42	69.02	43.37
Operating Income	-121.19	-126.04	-93.42	-69.02	-43.37
Other Income/Expense
Interest Income	4.27	8.17	1.32	0.12	0.03
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	4.27	0.00	0.00	0.00	0.00
Income
Income Before Tax	-116.91	-117.86	-92.09	-68.90	-43.34
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-116.91	-117.86	-92.09	-68.90	-43.34
Net Income - Continuous Operations	-116.91	-117.86	-92.09	-68.90	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-117.66	-122.54	-90.89	-67.58	-42.76
EBIT	-121.19	-126.04	-93.42	-69.02	-43.37
Depreciation & Amortization	3.53	3.50	2.53	1.43	0.61
Earnings Per Share
Basic EPS	-34.00	-2.00	-47.00	-42.00	-4611.00
Diluted EPS	-34.00	-2.00	-47.00	-42.00	-4611.00
Basic Shares Outstanding	3.44	67.19	1.98	1.67	0.01
Diluted Shares Outstanding	3.44	67.19	1.98	1.67	0.01